BioPorto sets October 7 investor meeting on commercial and clinical progress

Sep 24, 2026 07:17 (29d ago)

Verifying

BioPorto will host an investor meeting covering commercial, regulatory and strategic priorities.
The event is scheduled for October 7, 2026, from 3:00 p.m. to 5:30 p.m. CET.
BioPorto says the meeting will include an Adult Clinical Validation Study update and live Q&A.

The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.